ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2002

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions
Colorectal Cancer
Interventions
DRUG

gefitinib

Trial Locations (2)

78229

Institute for Drug Development, San Antonio

78284-7811

University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT00030524 - ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter